Nexalin Technology (NXL) Change in Receivables (2021 - 2026)
Nexalin Technology's quarterly Change in Receivables came in at -$755.0 in Q1 2026, down 290.66% year-on-year from $396.0 in Q1 2025, and down 102.06% quarter-over-quarter from $36729.0 in Q4 2025.
Nexalin Technology has reported Change in Receivables for 6 years, with the latest figure at -$755.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables fell 290.66% year-over-year to -$755.0; the trailing twelve-month figure through Mar 2026 stood at $32571.0 (up 681.08% YoY), and the FY2025 full-year result was $33722.0, up 817.86% from the prior year.
- Change in Receivables for Q1 2026 stood at -$755.0, down from $36729.0 in the prior quarter.
- The five-year high for Change in Receivables was $53540.0 in Q1 2022, with the low at -$34980.0 in Q2 2022.
- Average Change in Receivables over 5 years is $2329.2, with a median of -$427.5 recorded in 2024.
- Year-over-year, Change in Receivables plunged 965.22% in 2024 and soared 1071.95% in 2025.
- Tracing NXL's Change in Receivables over 5 years: stood at -$5477.0 in 2022, then tumbled by 59.36% to -$8728.0 in 2023, then surged by 135.91% to $3134.0 in 2024, then soared by 1071.95% to $36729.0 in 2025, then plunged by 102.06% to -$755.0 in 2026.
- The last three Change in Receivables figures came in at -$755.0 (Q1 2026), $36729.0 (Q4 2025), and -$3403.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 42.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | -444.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -13.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 117.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 117.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | -124.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -141.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 123.50 Mn |
| 10 | Nexalin Technology | 11.19 Mn | 8.48 Mn | 13,133.00 | -755.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -755.00 |
| Mar 31, 2026 | -755.00 |
| Dec 31, 2025 | 36,729.00 |
| Dec 31, 2025 | 36,729.00 |
| Jun 30, 2025 | -3,403.00 |
| Jun 30, 2025 | -3,403.00 |
| Mar 31, 2025 | 396.00 |
| Mar 31, 2025 | 396.00 |
| Dec 31, 2024 | 3,134.00 |
| Dec 31, 2024 | 3,134.00 |
| Sep 30, 2024 | -1,393.00 |
| Sep 30, 2024 | -1,393.00 |
| Jun 30, 2024 | 2,033.00 |
| Jun 30, 2024 | 2,033.00 |
| Mar 31, 2024 | -100.00 |
| Mar 31, 2024 | -100.00 |
| Dec 31, 2023 | -8,728.00 |
| Dec 31, 2023 | -8,728.00 |
| Sep 30, 2023 | 161.00 |
| Sep 30, 2023 | 161.00 |
| Jun 30, 2023 | 10,772.00 |
| Jun 30, 2023 | 10,772.00 |
| Mar 31, 2023 | -1,325.00 |
| Mar 31, 2023 | -1,325.00 |
| Dec 31, 2022 | -5,477.00 |
| Dec 31, 2022 | -5,477.00 |
| Sep 30, 2022 | -13,336.00 |
| Sep 30, 2022 | -13,336.00 |
| Jun 30, 2022 | -34,980.00 |
| Jun 30, 2022 | -34,980.00 |
| Mar 31, 2022 | 53,540.00 |
| Mar 31, 2022 | 53,540.00 |
| Dec 31, 2021 | -564.00 |
| Dec 31, 2021 | -564.00 |